Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Acquisition

16 Feb 2016 17:10

RNS Number : 2543P
Creightons PLC
16 February 2016
 

 

For Immediate Release 16 February 2016

 

Creightons plc (the "Company", "Creightons" or "Cplc")

 

Acquisition of certain assets of Broad Oak Toiletries Ltd (in Administration) ("BOT")

 

The Company announces that today Potter & Moore (Devon) Ltd ("PMD"), a wholly-owned subsidiary of Creightons plc, has purchased certain assets of Broad Oak Toiletries Ltd (in Administration) to include all unencumbered plant and equipment but excluding assets subject to HP, all stock and the IP including formulations, manufacturing methods, manufacturing and component specifications.

BOT is a private UK company which operated in a similar area of the toiletries contract manufacturing market to the Company, mainly supplying small batch high value products to its customers. It is proposed that the assets being acquired will be used as part of the Company's operations in that market to increase capacity and the range of products available to customers. 

 

The last available audited accounts for BOT for the year ended 31 January 2015 reported a Loss before tax of £770,000 attributable to the assets subject to this purchase although this was based on Turnover of £19.081million. Given the current condition of BOT's business, the Company believes it can achieve sales of £3.2million for the year to 31 January 2017 thus making a positive contribution to the results of the Group. The Company anticipates that the wider range of production capabilities together with its existing excellent reputation for customer service will enable the Company to re-build relationships with BOT's customers and generate increased sales for the enlarged operation.

 

The total consideration for the purchase is £600,002 which will be paid in cash from the current reserves of the Company.

 

The gross value of the consideration amounting to £600,002 of the assets acquired will be allocated as follows in the consolidated accounts of Company:

- Fixed assets £540,000

- IP £10,002

- Stock £50,000

Total £600,002

 

Stock valued at £168,000 will be acquired by PMD for £50,000 and therefore the Company will account for this as a debit to Gross Assets but then a credit to goodwill as negative goodwill of £118,000. This is because PMD will acquire it as part of the transaction for £50,000 and may only be able to realise value from it if existing contracts are retained.

 

The Company anticipates that the additional assets will enable it to increase consolidated group sales by some £3.2million in the first full year through additional capacity, supplying new customers and offering existing customers products previously manufactured by BOT.

 

Neither PMD nor the Company has agreed to take on any employees from BOT, and the Company understands that all were made redundant before the acquisition of these assets. 

 

Speaking after the transaction had been completed, the Company's Chairman, Mr William McIlroy said: "We are very excited by this acquisition which complements the Company's existing production capabilities which we are confident will add to both the Company's sales and profits by enabling us to produce and supply new product ranges such as Soap, Candles and Powder products to an enlarged customer base who will benefit from our superior supply chain management."

 

End

 

For further information, contact Mr Paul Forster, MD UK Operations or Mr Nick O'Shea, Company Secretary on 01733 281000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDQLFFQLFBBBD
Date   Source Headline
29th Oct 20213:53 pmRNSDirector/PDMR Shareholding
28th Oct 202111:24 amRNSDirector/PDMR Shareholding
22nd Oct 20217:00 amRNSDirector/PDMR Shareholding, Total Voting Rights
21st Oct 20217:00 amRNSDirector/PDMR Shareholding
5th Oct 20213:57 pmRNSDirector/PDMR Shareholding
5th Oct 20213:51 pmRNSDirector/PDMR Shareholding
4th Oct 20219:12 amRNSTotal Voting Rights
30th Sep 20216:29 pmRNSListing Application
27th Sep 20217:00 amRNSAcquisition of Brodie and Stone
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
17th Sep 20217:00 amRNSBlock listing Interim Review
3rd Sep 20219:30 amRNSTotal Voting Rights
26th Aug 202111:19 amRNSFinal Dividend Declaration
25th Aug 20211:34 pmRNSResults of AGM, Final Dividend Declaration
4th Aug 20211:47 pmRNSEmma Hardie Ltd - Q&A video available
29th Jul 20217:00 amRNSAcquisition of Emma Hardie Limited and TVR
21st Jul 20212:05 pmRNSSecond Price Monitoring Extn
21st Jul 20212:00 pmRNSPrice Monitoring Extension
21st Jul 202111:05 amRNSSecond Price Monitoring Extn
21st Jul 202111:00 amRNSPrice Monitoring Extension
21st Jul 20219:05 amRNSSecond Price Monitoring Extn
21st Jul 20219:00 amRNSPrice Monitoring Extension
21st Jul 20217:00 amRNSPreliminary Results - for year ended 31 March 2021
20th Jul 20214:17 pmRNSNotice of Results and Presentation
6th Jul 20213:24 pmRNSUpdate on Notice of Final Results
24th Jun 20217:00 amRNSPresentation on Final Results
26th Mar 202111:35 amRNSChange of Director's Role
18th Mar 20217:00 amRNSBlock Listing Six Monthly Review
16th Mar 202111:42 amRNSShare Option Grant
9th Mar 20219:52 amRNSDirector/PDMR Shareholding
25th Feb 20212:54 pmRNSDirector/PDMR Shareholding
24th Feb 20215:28 pmRNSFurther Statement regarding Innovaderma
24th Feb 20214:46 pmRNSForm 8.3 - Creightons PLC
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 20218:43 amRNSForm 8 (OPD) Creightons plc
5th Feb 20215:15 pmRNSForm 8.3 - Creightons plc
4th Feb 20216:28 pmRNSRule 2.9 Announcement
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
3rd Feb 202112:14 pmGNWForm 8.3 - [Creightons plc] - Opening Disclosure - (CGWL)
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 20217:00 amRNSStatement regarding Innovaderma plc
9th Dec 20207:00 amRNSHalf-year Report
24th Nov 20209:28 amRNSChange of Auditor
24th Nov 20209:19 amRNSInterim Results Presentation
30th Sep 20205:39 pmRNSResult of AGM
18th Sep 202011:37 amRNSBlock listing Interim Review
16th Sep 202011:49 amRNSHolding(s) in Company
8th Sep 20205:47 pmRNSDirector/PDMR Shareholding
8th Sep 20204:50 pmRNSReport and Accounts, AGM and Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.